Granahan Investment Management, LLC Nektar Therapeutics Transaction History

Granahan Investment Management, LLC

  • $2.38 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
$57.4 - $108.44 $8.98 Million - $17 Million
-156,517 Closed
0 $0
Q4 2017

Feb 12, 2018
SELL
$23.02 - $60.5 $7.53 Million - $19.8 Million
-327,283 Reduced 67.65%
156,517 $9.35 Million
Q3 2017

Nov 14, 2017
BUY
$17.79 - $24.0 $8.61 Million - $11.6 Million
483,800
483,800 $11.6 Million

Others Institutions Holding NKTR

# of Institutions
147
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $193M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email